Alumis Inc. Common Stock (ALMS) has 18 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist AyurMaya Capital Management Company, LP mit 15,139,707 Aktien. Weitere bedeutende Anteilseigner sind Foresite Capital Management VI LLC und Foresite Labs, LLC.
In den letzten 12 Monaten haben Insider 66 Transaktionen in ALMS Aktien getätigt — 60 Käufe (im Wert von $96.96M) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
ALMS Insider-Beteiligungen
Größter Aktionär
AyurMaya Capital Management Company, LP
15,139,707 Aktien
Käufe (12 Monate)
60
$96.96M Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Ayurmaya Capital Management Company, Lp |
10 Percent Owner, Other: See Remarks |
15,139,707 |
2025-05-23 |
|
| 2 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 3 |
Foresite Labs, Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 4 |
Tananbaum James B. |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 5 |
Akkaraju Srinivas |
Director |
1,853,488 |
2026-01-13 |
|
| 6 |
Babler Martin |
President, CEO and Chairman |
745,875 |
2026-01-28 |
|
| 7 |
Drappa Jorn |
Chief Medical Officer |
221,450 |
2026-01-28 |
|
| 8 |
Schroer John R. |
Chief Financial Officer |
202,225 |
2026-01-28 |
|
| 9 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
190,875 |
2026-01-28 |
|
| 10 |
Bradley Mark Christopher |
Chief Development Officer |
190,225 |
2026-01-28 |
|
| 11 |
Pangali Sanam |
Chief Legal Officer |
186,200 |
2026-01-28 |
|
| 12 |
Srivastava Sapna |
Director |
49,800 |
2025-08-01 |
|
| 13 |
Tetrault Lynn A. |
Director |
49,800 |
2025-08-01 |
|
| 14 |
Machado Patrick |
Director |
49,800 |
2025-08-01 |
|
| 15 |
Yao Zhengbin |
Director |
49,800 |
2025-08-01 |
|
| 16 |
Richardson Derrick |
SVP, People and Culture |
42,800 |
2025-07-31 |
|
| 17 |
Colowick Alan |
Director |
16,104 |
2025-04-03 |
|
| 18 |
Goldstein David M |
Chief Scientific Officer |
8,994 |
2026-02-11 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
Unbekannt |
- |
- |
- |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
RSU-Zuteilung |
186,200 |
$26.31 |
$4.9M |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
RSU-Zuteilung |
190,225 |
$26.31 |
$5M |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
RSU-Zuteilung |
221,450 |
$26.31 |
$5.83M |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
RSU-Zuteilung |
216,675 |
$26.31 |
$5.7M |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
RSU-Zuteilung |
202,225 |
$26.31 |
$5.32M |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU-Zuteilung |
190,875 |
$26.31 |
$5.02M |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
RSU-Zuteilung |
745,875 |
$26.31 |
$19.62M |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
588,235 |
$17.00 |
$10M |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
64,969 |
$8.95 |
$581.47K |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
66,027 |
$8.18 |
$540.1K |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
100,000 |
$7.75 |
$775K |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
96,000 |
$7.55 |
$724.8K |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
86,350 |
$7.46 |
$644.17K |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
38,702 |
$7.64 |
$295.68K |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
48,537 |
$7.64 |
$370.82K |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
